Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

Zymeworks BC Inc. (ZYME) Create: Alert

All | News | Filings
Date FiledTypeDescription
11/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
07/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2022 4 Klompas Neil A (COO) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 1,525 shares @ $4.51, valued at $6.9k
03/11/2022 4 Astle Christopher (SVP & CFO) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 125,000 options to buy @ $7, valued at $875k
03/11/2022 4 Klompas Neil A (COO) has filed a Form 4 on Zymeworks Inc.
Txns: Sold 2,979 shares @ $6.88, valued at $20.5k
Exercised 2,500 restricted stock units @ $0
Exercised 2,708 restricted stock units @ $0
Granted 200,000 options to buy @ $7, valued at $1.4M
03/11/2022 4 Josephson Neil (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Exercised 729 restricted stock units @ $0
Exercised 1,666 restricted stock units @ $0
03/04/2022 3 Astle Christopher (SVP & CFO) has filed a Form 3 on Zymeworks Inc.
01/18/2022 4 Galbraith Kenneth (Chair, President & CEO) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 500,000 options to buy @ $14.97, valued at $7.5M
01/18/2022 3 Galbraith Kenneth (Chair, President & CEO) has filed a Form 3 on Zymeworks Inc.
01/11/2022 4 Josephson Neil (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Bought 1,400 shares @ $14.27, valued at $20k
Bought 3,600 shares @ $14.28, valued at $51.4k
01/07/2022 4 Josephson Neil (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 65 shares @ $13.94, valued at $906.1
01/07/2022 4 Polverino Anthony J. (Chief Scientific Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 74 shares @ $13.94, valued at $1k
01/07/2022 4 Klompas Neil A (COO & CFO) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 277 shares @ $13.94, valued at $3.9k
11/12/2021 4 Josephson Neil (Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 105,943 options to buy @ $21.18, valued at $2.2M
Granted 17,657 restricted stock units @ $0
09/02/2021 4 Polverino Anthony J. (Chief Scientific Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Exercised 4,900 options to buy @ $15, valued at $73.5k
07/16/2021 4 Tehrani Ali (CEO) has filed a Form 4 on Zymeworks Inc.
Txns: Exercised 3,800 shares @ $4.2713, valued at $16.2k
Sold 3,800 shares @ $36, valued at $136.8k
Exercised 41,191 shares @ $4.2643, valued at $175.7k
Sold 41,191 shares @ $36, valued at $1.5M
Exercised 3,800 options to buy @ $0
Exercised 41,191 options to buy @ $0
07/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2021 4 O'Driscoll Kathryn (Chief People Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 510 shares @ $29.49, valued at $15k
07/08/2021 4 Polverino Anthony J. (Chief Scientific Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 454 shares @ $29.49, valued at $13.4k
07/08/2021 4 Klompas Neil A (CFO) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 299 shares @ $29.49, valued at $8.8k
07/08/2021 4 Priour James (Chief Commercial Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 510 shares @ $29.49, valued at $15k
07/08/2021 4 Josephson Neil (Interim Chief Medical Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 461 shares @ $29.49, valued at $13.6k
05/25/2021 3 Josephson Neil (Interim Chief Medical Officer) has filed a Form 3 on Zymeworks Inc.
05/07/2021 4 Neu Kelvin (Director) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 9,000 options to buy @ $29.49, valued at $265.4k
05/07/2021 4 Hillan Kenneth J. (Director) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 9,000 options to buy @ $29.49, valued at $265.4k
05/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/07/2021 4 Sacks Natalie (Director) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 9,000 options to buy @ $29.49, valued at $265.4k
05/07/2021 4 Cox Troy (Director) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 9,000 options to buy @ $29.49, valued at $265.4k
05/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/07/2021 4 Zoth Lota S. (Director) has filed a Form 4 on Zymeworks Inc.
Txns: Granted 9,000 options to buy @ $29.49, valued at $265.4k
04/13/2021 4 Priour James (Chief Commercial Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Sold 950 shares @ $27.9296, valued at $26.5k
Exercised 2,266 restricted stock units @ $0
03/17/2021 4 O'Driscoll Kathryn (Chief People Officer) has filed a Form 4 on Zymeworks Inc.
Txns: Sold 786 shares @ $34.72, valued at $27.3k
Exercised 837 options to buy @ $34.24, valued at $28.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy